| abstract |
The present invention relates to a novel adjuvant system comprising a polyoxyethylene alkyl ether or ester alkyl surfactant in combination with at least one additional non-ionic surfactant, preferably, the additional non-ionic surfactant is a series octoxynol (TRITON ™). The present invention provides novel adjuvants, vaccines containing them and methods for their manufacture and formulation in vaccines. The use of adjuvants or vaccines of the present invention, in the prophylaxis or therapy of a disease is also provided. |